染色内视镜试剂市场 - 全球产业规模、份额、趋势、机会及预测（按产品、应用、最终用户、地区和竞争格局划分），2021-2031年

全球染色内视镜药物市场预计将从 2025 年的 2.2 亿美元成长到 2031 年的 3.2 亿美元，复合年增长率为 6.44%。

这些试剂由特殊的生化染色剂组成，在内镜检查过程中局部涂抹，可突出显示黏膜形态，并有助于检测胃肠道病变。市场成长的主要驱动因素是全球消化器官系统恶性肿瘤发生率的上升趋势，以及早期诊断准确性对改善患者预后的重要性日益凸显。此外，各国广泛开展癌症筛检计画以及老龄化人口不断增长（胃肠道疾病高风险族群）也大大推动了对这些诊断辅助工具的需求成长。

市场面临的主要障碍是虚拟染色内视镜系统的日益普及。该系统无需耗时的物理染色步骤即可实现数位化组织增强。这种数位技术的操作优势对传统化学试剂的常规应用构成了竞争威胁。然而，由于目标疾病的高发生率，有效检测仍具有临床意义。例如，美国癌症协会估计，到2025年，美国将有约154,270人被诊断出罹患大肠癌，凸显了对精准诊断工具的持续需求。

市场驱动因素

全球胃肠道疾病发生率的不断上升是染色内视镜造影剂市场的主要驱动力，也因此产生了对卓越视觉化能力的迫切临床需求。随着胃肠道恶性肿瘤发生率的不断攀升，内视镜医师越来越依赖特殊染色剂来识别标准影像可能遗漏的细微病变，这对于检测大肠直肠癌病例中的发育不良至关重要。根据国际癌症研究机构（IARC）于2025年2月发布的关于结直肠癌宣传月的声明，全球每年约有190万例新发结直肠癌病例，这确保了用于高清监测检测和靶向切片检查的造影剂需求将持续增长。

同时，人们对结直肠癌筛检计画的日益关注显着增加了全球范围内的诊断程序数量，从而推动了市场扩张。公共卫生宣传活动和国家倡议有效地促进了预防性筛检的参与，使得需要使用染色内视镜辅助检查的患者群体不断扩大。根据美国国家大肠直肠癌圆桌会议2025年8月报告，2024年美国医疗机构的大肠癌筛检数量增加至3,617,246例。检测量的成长也反映在产业的财务表现中。例如，Olympus Corporation2025年5月报告称，其内视镜解决方案部门的营收上年度增8.4%，凸显了诊断内视镜领域的稳健成长。

市场挑战

全球染色内视镜市场成长的关键障碍之一是虚拟染色内视镜系统与标准临床工作流程的快速整合。与传统的手动应用生化染色剂来观察黏膜细节的方法不同，数位化替代方案可透过整合的内视镜软体实现组织即时显色。这种操作效率的提升省去了物理染色剂的准备和清理时间，显着简化了医疗团队的工作流程。因此，医疗机构对耗材染色剂的依赖性日益降低，并开始采用这些内建的数位化功能，这直接影响了化学品製造商的经常性收入。

考虑到全球胃肠道疾病负担之重，所需的检测数量庞大，这种市场份额的下降尤其显着。对筛检的巨大需求正越来越多地透过数位化解决方案而非化学辅助手段来满足。例如，全球癌症观察站报告称，到2024年，胃癌约占全球新增癌症病例的4.9%，这反映了该诊断领域的规模之大。随着医疗专业人员转向数位化视觉化来应对这一患者负担，物理染色内视镜试剂的常规使用正在持续下降。

市场趋势

口服给药系统的开发正显着地推动市场发展，为传统的染料喷洒方法提供了标准化、以患者为中心的替代方案。这一趋势的核心是缓释亚甲基蓝片剂的商业性化应用，该片剂旨在特异性在大肠内崩坏，从而有效消除了导管给药方法通用的粘膜覆盖不均和检测延迟等问题。这些药物创新的商业性成功体现在领先製造商强劲的财务表现上。例如，Cosmo Pharmaceuticals在2025年7月公布的上半年经常性收入为4,190万欧元，这主要得益于其专有的胃肠道产品（包括先进的给药系统）的日益普及。

同时，人工智慧辅助诊断平台与染色内视镜技术的融合正在建立新的临床标准。在该技术中，化学试剂作为电脑辅助检测（CADe）系统中重要的造影增强剂。这种协同方法利用生化染料突出细微粘膜异常的能力，并透过深度学习演算法进行处理，从而提高病变检出率并最大限度地减少操作者差异。技术的融合正在推动诊断行业的显着增长；FUJIFILM Holdings株式会社于2025年5月宣布，其医疗保健部门的收入将达到1.226万亿日元，这表明市场对支持这些混合诊断工作流程的先进成像生态系统有着强劲的需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章全球色素内视镜药物市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产物（吸收性造影、造影、反应性造影）
  • 透过用途（大肠/直肠、食道、胃）
  • 按最终使用者（门诊手术中心、诊断中心、医院/专科诊所、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美染色内视镜药物市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7.欧洲色素内视镜检查剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8.亚太地区色素内视镜药物市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲染色内视镜试剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10.南美色素内视镜製剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球染色内视镜试剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Merck & Co., Inc.
• Enzo Life Sciences Inc
• Thermo Fisher Scientific Inc
• Cosmo Pharmaceuticals SA
• Loba Chemie Pvt Ltd
• Provepharm SAS
• Sisco Research Laboratories Pvt Ltd
• Medtronic PLC
• Boston Scientific Corp

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Chromoendoscopy Agents Market is projected to expand from USD 0.22 Billion in 2025 to USD 0.32 Billion by 2031, registering a CAGR of 6.44%. These agents consist of specialized biochemical dyes and stains applied locally during endoscopic examinations to highlight mucosal topography and facilitate the detection of gastrointestinal lesions. Market growth is primarily driven by the increasing global prevalence of gastrointestinal malignancies and a heightened focus on early diagnostic accuracy to enhance patient prognosis. Additionally, the proliferation of national cancer screening initiatives, alongside an aging population prone to digestive conditions, provides a strong foundation for the rising consumption of these diagnostic aids.

A major obstacle facing the market is the rising utilization of virtual chromoendoscopy systems, which offer digital tissue enhancement without the time-intensive process of applying physical dyes. This operational advantage of digital technologies presents a competitive threat to the standard use of traditional chemical agents. However, the essential clinical requirement for effective detection persists due to the high incidence of target diseases. For instance, the American Cancer Society estimated in 2025 that approximately 154,270 individuals in the United States would be diagnosed with colorectal cancer, underscoring the continued need for accurate diagnostic tools.

Market Driver

The increasing global incidence of gastrointestinal disorders serves as a primary propellant for the Chromoendoscopy Agents Market, creating an urgent clinical demand for superior visualization capabilities. With the prevalence of gastrointestinal malignancies on the rise, endoscopists are depending more frequently on specialized dyes to identify subtle lesions that standard imaging might miss, a practice essential for detecting dysplasia in colorectal cancer cases. According to a February 2025 statement by the International Agency for Research on Cancer (IARC) regarding Colorectal Cancer Awareness Month, roughly 1.9 million new cases of colorectal cancer are diagnosed annually worldwide, ensuring a sustained and growing need for contrast agents used in high-definition surveillance and targeted biopsies.

Concurrently, heightened awareness regarding colorectal cancer screening programs is stimulating market expansion by significantly boosting the number of diagnostic procedures conducted globally. Public health campaigns and national initiatives are effectively driving participation in preventative screenings, resulting in a larger patient pool requiring endoscopic assessment with chromoendoscopy adjuncts. As reported by the National Colorectal Cancer Roundtable in August 2025, the number of patients screened for colorectal cancer in U.S. health centers rose to 3,617,246 in 2024. This increase in procedural volume is reflected in industry financial results; for example, Olympus Corporation reported in May 2025 that revenue for its Endoscopic Solutions segment grew by 8.4% over the prior fiscal year, highlighting robust growth in the diagnostic endoscopy sector.

Market Challenge

The principal hindrance to the growth of the Global Chromoendoscopy Agents Market is the swift integration of virtual chromoendoscopy systems into standard clinical workflows. In contrast to traditional methods that require the manual application of biochemical stains to reveal mucosal details, digital alternatives permit immediate tissue enhancement via integrated endoscopic software. This operational efficiency eliminates the preparation and cleaning time linked to physical dyes, significantly streamlining the workflow for medical teams. As a result, healthcare facilities are increasingly diminishing their dependence on consumable staining agents in favor of these built-in digital capabilities, which directly impacts the recurring revenue of chemical agent manufacturers.

This decline in market share is particularly significant given the substantial procedural volume necessary to manage the global burden of digestive diseases. The immense demand for screening is increasingly being addressed through digital solutions rather than chemical adjuncts. To highlight the scale of this diagnostic sector, the Global Cancer Observatory reported that stomach cancer accounted for approximately 4.9% of all new cancer cases globally in 2024. As medical professionals shift toward digital visualization to handle this patient load, the routine utilization of physical chromoendoscopy agents is experiencing a sustained reduction.

Market Trends

The development of oral delivery systems is significantly propelling the market forward by providing a standardized and patient-centric substitute for traditional dye spraying methods. This trend centers on the commercial release of delayed-release methylene blue tablets designed to disintegrate specifically within the colon, effectively removing the issues of uneven mucosal coating and procedural delays common with catheter-based applications. The commercial success of such pharmaceutical innovations is reflected in the strong financial results of major manufacturers; for instance, in July 2025, Cosmo Pharmaceuticals reported recurring revenues of €41.9 million for the first half of the year, a performance driven by the rising uptake of its proprietary gastrointestinal products, including these advanced delivery systems.

At the same time, the integration of chromoendoscopy with AI-assisted diagnostic platforms is setting a new clinical standard, wherein chemical agents function as essential contrast enhancers for Computer-Aided Detection (CADe) systems. This synergistic approach leverages the capacity of biochemical dyes to accentuate subtle mucosal abnormalities, which are subsequently processed by deep learning algorithms to enhance lesion detection rates and minimize operator variability. This convergence of technologies is fueling significant growth across the diagnostic industry; as noted by Fujifilm Holdings Corporation in May 2025, revenue for its Healthcare segment rose to ¥1,022.6 billion, indicating strong demand for advanced imaging ecosystems capable of supporting these hybrid diagnostic workflows.

Key Market Players

• Merck & Co., Inc.
• Enzo Life Sciences Inc
• Thermo Fisher Scientific Inc
• Cosmo Pharmaceuticals SA
• Loba Chemie Pvt Ltd
• Provepharm SAS
• Sisco Research Laboratories Pvt Ltd
• Medtronic PLC
• Boston Scientific Corp

Report Scope

In this report, the Global Chromoendoscopy Agents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chromoendoscopy Agents Market, By Product

• Absorptive Agents
• Contrast Agents
• Reactive Agents

Chromoendoscopy Agents Market, By Application

• Colorectal
• Esophageal
• Gastric

Chromoendoscopy Agents Market, By End-Users

• Ambulatory Surgery Centers
• Diagnostic Centers
• Hospitals & Specialty Clinics
• Others

Chromoendoscopy Agents Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chromoendoscopy Agents Market.

Available Customizations:

Global Chromoendoscopy Agents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chromoendoscopy Agents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Absorptive Agents, Contrast Agents, Reactive Agents)
  • 5.2.2. By Application (Colorectal, Esophageal, Gastric)
  • 5.2.3. By End-Users (Ambulatory Surgery Centers, Diagnostic Centers, Hospitals & Specialty Clinics, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Chromoendoscopy Agents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End-Users
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Chromoendoscopy Agents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Users
  • 6.3.2. Canada Chromoendoscopy Agents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Users
  • 6.3.3. Mexico Chromoendoscopy Agents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Users

7. Europe Chromoendoscopy Agents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End-Users
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Chromoendoscopy Agents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Users
  • 7.3.2. France Chromoendoscopy Agents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Users
  • 7.3.3. United Kingdom Chromoendoscopy Agents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Users
  • 7.3.4. Italy Chromoendoscopy Agents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Users
  • 7.3.5. Spain Chromoendoscopy Agents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Users

8. Asia Pacific Chromoendoscopy Agents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End-Users
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Chromoendoscopy Agents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Users
  • 8.3.2. India Chromoendoscopy Agents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Users
  • 8.3.3. Japan Chromoendoscopy Agents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Users
  • 8.3.4. South Korea Chromoendoscopy Agents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Users
  • 8.3.5. Australia Chromoendoscopy Agents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Users

9. Middle East & Africa Chromoendoscopy Agents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End-Users
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Chromoendoscopy Agents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Users
  • 9.3.2. UAE Chromoendoscopy Agents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Users
  • 9.3.3. South Africa Chromoendoscopy Agents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Users

10. South America Chromoendoscopy Agents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End-Users
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Chromoendoscopy Agents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Users
  • 10.3.2. Colombia Chromoendoscopy Agents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Users
  • 10.3.3. Argentina Chromoendoscopy Agents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Users

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Chromoendoscopy Agents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck & Co., Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Enzo Life Sciences Inc
• 15.3. Thermo Fisher Scientific Inc
• 15.4. Cosmo Pharmaceuticals SA
• 15.5. Loba Chemie Pvt Ltd
• 15.6. Provepharm SAS
• 15.7. Sisco Research Laboratories Pvt Ltd
• 15.8. Medtronic PLC
• 15.9. Boston Scientific Corp

16. Strategic Recommendations

17. About Us & Disclaimer